Money Concepts Capital Corp
Source: SEC Form 13F · as of Mar 2026Money Concepts Capital Corp holds 22 biotech & pharma companies tracked by BioSniper, totaling $85.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$85.4M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 14,054 | $12.9M |
| JNJJOHNSON & JOHNSON | 51,138 | $12.5M |
| GILDGILEAD SCIENCES, INC. | 79,857 | $11.1M |
| CAHCardinal Health Inc. | 47,157 | $10.0M |
| ABBVAbbVie Inc. | 42,448 | $9.2M |
| PFEPFIZER INC | 254,239 | $7.1M |
| NVONovo Nordisk A/S | 123,261 | $4.5M |
| AMGNAMGEN INC | 9,312 | $3.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 11,844 | $3.2M |
| AZNASTRAZENECA PLC | 15,801 | $3.1M |
| MRKMerck & Co., Inc. | 18,737 | $2.3M |
| ABTABBOTT LABORATORIES | 12,418 | $1.3M |
| MCKMcKesson Corporation | 1,339 | $1.2M |
| ELVElevance Health Inc. | 3,133 | $917K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 14,573 | $804K |
| GMOptec International, Inc. | 8,523 | $635K |
| ZBHZimmer Biomet Holdings Inc. | 3,610 | $326K |
| PMPhilip Morris International Inc | 1,751 | $290K |
| DFTXDefinium Therapeutics Inc. | 13,000 | $246K |
| CPRXCATALYST PHARMACEUTICALS, INC. | 9,430 | $233K |
| CRSPCRISPR Therapeutics AG | 4,738 | $225K |
| OGNOrganon & Co. | 11,833 | $71K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.